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Introduction
Gastric cancer (GC) is the second most common cause 
of cancer-related death in the world, with a wide variation 
in incidence rates across the global geography (Goh et al., 
2014; Karimi et al., 2014). The incidence of GC in Iran 
is approximated at 7300 cases per year (Haidari et al., 
2012; Massarrat and Stolte, 2014), is amongst the most 
common cancer in males, and it is reported to be the third 
most common cancer after breast and colorectal cancers in 
females. GC is also the first cause of cancer related death 
of both sexes in Iran (Kolahdoozan et al., 2010; Aghaei 
et al., 2013; Liu et al., 2013).
Despite many attempts, the treatment of gastric cancer 
remains challenging, primarily because most patients 
present in an advanced state of the disease(Piazuelo and 
Correa, 2013). Only complete resection with negative 
microscopic margins (R0 resection) of all gross findings 
provides a long-term survival benefit (Koessler et al., 
2014).
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Abstract
 Background: Gastric cancer (GC) is one the common lethal cancers in Iran. Detection of GC in the early stages 
would assesses to improve the survival of patients. In this study, we attempt to evaluate the accuracy of EUS in 
detection depth of invasion of GC among Iranian Patients. Materials and Methods: This study is a retrospective 
study of patients with pathologically confirmed GC. They underwent EUS before initiating the treatment. The 
accuracy of EUS and agreement between the two methods was evaluated by comparing pre treatment EUS 
finding with post operative histopathological results. Results: The overall accuracy of EUS for T and N staging 
was 67.9% and 75.47, respectively. Underestimation and overestimation was seen in 22 (14.2%) and 40 (25.6%) 
respectively. The EUS was more accurate in large tumors and the tumors located in the middle and lower parts of 
the stomach. The EUS was more sensitive in T3 staging. The values of weighted Kappa from the T and N staging 
were 0.53 and 0.66, respectively. Conclusions: EUS is a useful modality for evaluating the depth of invasion of 
GC. The accuracy of EUS was higher if the tumor was located in the lower parts of the stomach and the size of 
the tumor was more than 3 cm. Therefore, judgments made upon other criteria evaluated in this study need to 
be reconsidered. 
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Of recent, the detection of gastric cancer in its early 
stages along with the consequent minimal invasive 
treatment methods such as endoscopic mucosal resection 
or laparoscopic gastrectomy are gaining importance 
(Park et al., 2011; Kim, 2012). Based on the views of 
the Japanese Gastric Cancer Association (JGCA), early 
gastric cancer and stage 1A gastric cancer can be treated 
by means of endoscopy (Japanese Gastric Cancer, 1998). 
In this context, accurate preoperative determination of the 
GC stage is essential in the selection of an appropriate 
therapeutic mode. Previously, precise preoperative 
staging was not essential because the exact stage did not 
alter treatment plans (Garlipp et al., 2011). Endoscopic 
ultrasonography (EUS), which is considered to be the 
method of choice for locoregional staging, was commonly 
used for the differentiation of mucosal from submucosal 
lesions (Ganpathi et al., 2006; Jurgensen et al., 2013; 
Karimi et al., 2014). EUS actually is considered as one 
of the best diagnostic modalities for local and regional 
staging of gastric cancer (Kikuchi et al., 2011; Kim, 
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2012; Jurgensen et al., 2013). The accuracy of EUS in the 
determination of T (scoring) is greater than 80%;although 
it could be influenced by endoscopic findings, location 
and size of tumors. In this view, there is controversy 
regarding the accuracy of EUS in anatomically defining 
of the extent of tumor invasion. Therefore the present 
study was conducted to evaluate the accuracy of EUS in 
determining the depth of GC invasion in comparison to 
surgical pathology results. 
Materials and Methods
Design and patients
This study was conducted retrospectively at Firoozgar 
Hospital among patients who underwent EUS for the 
determination of local invasion of gastric tumors before 
surgical intervention, between 2009-2013
During this period the medical records of patients who 
referred to our center with a histopathologicaly confirmed 
diagnosis of gastric cancer and also underwent EUS for 
determining the depth of tumor invasion prior to treatment 
were studied. As a regular practice,once gastric cancer is 
diagnosed by histopathology, EUS and CT-scan are used 
to determine stages of tumore. The following patients 
were excluded from study for the following reasons:1) 
ambiguous pathological staging; 2) having received 
neoadjuvant chemotherapy or chemoradiotherapy; 3) 
having metastatic cancer or was considered as non 
operable gastric cancer. 
Endoscopic ultrasonography exam
The instrument used for EUS exams was an ultrasound 
UM-3R, with a frequency of 20MHZ with a depth of 
4 centimeters. The patients underwent conventional 
endoscopy before EUS evaluation to morphologically 
asses lesions and for obtaining biopsy. Local oropharyngeal 
anesthesis was administered with lidocain (5%) for 
all. Intravenous midazolam and petedin were used for 
sedation, under the supervision of an anesthesiologist.
The EUS was performed by an experienced 
gastroenterologist with a track record of more than 1000 
EUS per year. For the EUS procedure, as the scope 
was advanced toward the tumor, the stomach wall was 
examined as follow; mucosa was defined as a hyperecho 
in the first layer,hypoecho in the second layer,. hyperchoic 
layer in the third layer, the hypoechoic zone in the forth 
layer, and the fifth layer included hyperechoic layer 
corresponds to the subserrosa and serosa. The extent of 
invasion was assessed according to the infiltration of 
tumor into each layer. 
Surgical procedures
Surgical intervention was based on the Japanese 
Gastric Cancer Association (JGCA ) classification. Tumor 
location were classified according to the longitudinal axis 
of the stomach as three zones: upper, middle and lower 
third. Total gastrectomy with Roux en Y reconstruction 
was considered for tumors in the upper third of the 
stomach. In cases of subtotal gastrectomy, this orBilroth 
reconstructions were performed appropriately. The 
surgical specimens were then referred for histopathologic 
evaluation.
Histopathology evaluation:
The histopathological exams of surgically resected 
tissues were performed on 2-5 millimeter thick sections. 
The specimens were stained with Hematoxyline and Eosin 
(HandE).The size of tumors were reported as ≤3 and >3 
centimeters. Histopathological findings were classified 
according to the World Health Organization (WHO).
Undifferentiated types were defined as poorly differentiated 
adenocarcinoma, signet ring cell adenocarcinoma and 
mucinous adenocarcinoma. 
Statistic analysis
The accuracy and sensitivity of EUS in the staging 
of gastric cancer were assessed using histopathological 
staging of surgically resected specimens as the gold 
standard. Data was analyzed using STATA software, 
version 12 (StataCorp, Texas, USA). Univariate analysis 
was performed by chi-square and the weighted Kappa test 
was used to evaluate the consistency between the EUS and 
histopathological staging of gastric cancer. 
Ethics
The ethics committee of Firoozgar hospital approved 
this study in accordance to the declaration of Helsinki. 
Results 
Patients characteristics
A number of 106 patients were enrolled in this study. 
The mean age of patients was 63.3±11.9, of them 48 (45.8) 
were female. The average size of tumors was more than 
three centimeters 63 (59.4%). With consideration to the 
location of lesions, the main part of tumors was located in 
the middle third 63 (59.4%), and also 15 (14.1%) and 28 
(26.4%) for upper and lower third of stomach, respectively. 
The main macroscopic type of tumors was non-depressed 
89(84.0%).
Regarding T staging during EUS, T1, T2, T3 and T4 
were observed in 8 (7.55%), 32 (39.1%), 52 (49.0%) and 
14 (13.2%), respectively.
Surgical and pathological results
Surgical intervention of GC comprised of total 
gastrectomy and subtotal gastrectomy. In this regard 49 
(46.2%) subjects underwent total gastrectomy. None of 
them benefitted from endoscopic resection. The pathology 
results indicated that an undifferentiated type was seen in 
72 (67.9%) cases. According to the T staging, T1, T2, T3 
and T4 were seen in 13 (12.2%), 27 (25.4%), 41 (38.6%), 
and 25 (23.5%), respectively.
Comparison of EUS findings with pathological results
In 67.92 % of patients, the EUS T staging concurred 
with their pathological staging. Underestimation and 
overestimation were seen in 13 (12.2%) and 13 (12.2%), 
respectively. The sensitivity/PPV for EUS staging for 
stages T1, T2, T3 and T4 was 36.6%/ 50.0 %, 72.4%/65.6%, 
80.4%/63.4% and 48.0%/85.71%, respectively. Also the 
overall accuracy for T staging by EUS was 67.9% (Table 
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1). The sensitivity/PPV for EUS staging for stages 
N0, N1, N2 and N3 was 62.5%/68.1%, 77.7%/70.0%, 
75.8%/84.6% and 88.2%/83.3%, respectively. Also the 
overall accuracy for N staging by EUS was 75.4% (Table 
1).
Based on the EUS and histopathology staging, 
consistency in the endoscopic T staging and N staging 
was evaluated. The observed agreement for T and N 
staging were 67.9 and 75.4, respectively. Also the values 
of weighted Kappa for T and N staging were 0.53 and 
0.66, respectively (Table 2). 
With consideration to the tumor size, in those with 
a tumor size of more than 3 cm; 69.8% of EUS staging 
concurred to the corresponding pathologic findings. But 
this concurrence was 50.8% for tumors less than 3 cm 
in size. This concurrence was more prominent in T1 
and T2 staging. Regarding the location of tumors; there 
was greater accuracy in the middle and lower part of the 
stomach (Table 3).
Discussion
For over a decade, EUS was considered a very high 
accuracy modality for T staging in GC (Lee et al., 2005; 
De Angelis et al., 2013). Some previous reports have 
illustrated the superiority in the accuracy of EUS compared 
to conventional CT scanning or MRI, in the detection of 
tumor invasion in gastric cancer (Mandai and Yasuda, 
2012; De Angelis et al., 2013). It is also reported that in 
gastric cancer, the invasion level correlates with lymph 
node metastasis; therefore differentiations between T 
staging levels have become of greater significance (Mouri 
et al., 2009; Yoshino et al., 2012). EUS has the capability 
of illustrating the stomach wall layers comprehensively 
and thus can evaluate the level of tumor infiltration more 
accurately. 
In the present study we have found that the accuracy 
of EUS concerning T staging and nodular involvement 
in comparison to post surgery histopathology studies 
are about 68% and 75.4% respectively (Tables 2,3) 
; comparable with other studies (Puli et al., 2008).
Based on previous reports, the accuracy of EUS in T 
staging could reached to 93% with a lower rate of over 
or underestimation. In 1991 Botet et al reported a 92% 
accuracy of EUS with its corresponding pathological 
findings (Botet and Lightdale, 1992). After which many 
studies were carried out to determine the accuracy of 
EUS in comparison to pathology findings (Botet and 
Lightdale, 1995; Opacic and Rustemovic, 2003; Wang 
et al., 2014). In this context , a meta analysis by Puli et 
al reported that the sensitivity and specificity of EUS 
in gastric cancer staging was more than 80% and 90% 
respectively (Puli et al., 2008). In addition, another meta 
analysis by Mocellin revealed that the sensitivity and 
specificity of EUS reached 86% and 91%(Mocellin et al., 
2011). However, other studies have not shown the same 
results and while reporting figures in the range of 60-90% 
(Bohle et al., 2011).
The accuracy of EUS in T staging, depends on 
the depth of tumor and the changing of stomach layer 
anatomy. Furthermore, previous studies revealed that 
depressed, ulcerative and undifferentiated gastric cancers 
are associated with a lower accuracy in EUS staging. 
It is noteworthy that all types of infiltration have been 
taken into account in our study, but our results were not 
Table 1. T and N Staging: Histopathology and Endoscopic Ultrasound (EUS)
 Histopathologic staging Sensitivity PPV* Overall accuracy 
  (%) (%) (%)
EUS T staging  T1 T2 T3 T4 Total
 T1 4 4 0 0 8 36.36 50 67.92
 T2 5 21 6 0 32 72.41 65.62
 T3 2 4 33 13 52 80.48 63.46
 T4 0 0 2 12 14 48 85.71
 Total 11 29 41 25 106  
EUS N staging  N0 N1 N2 N3 Total  
 N0 15 5 2 0 22 62.5 68.18 75.47
 N1 6 28 4 2 40 77.77 70
 N2 3 1 22 0 26 75.86 84.61
 N3 0 2 1 15 18 88.23 83.33
 Total 24 36 29 17 106
*Positive predictive value
Table 2. Analysis of the Degree of Consistency between 
Endoscopic Ultrasound (EUS )and Histopathology (the 
Value of Weighted Kappa) 
Staging Observed Expected  Kappa SE*
  agreement agreement 
 (%) (%)
T staging 67.92 30.7 0.53 0.05
N staging 75.47 26.95 0.66 0.05
*Standard error
Table 3. EUS Accuracy for Tumor Depth
 Correct Incorrect Accuracy
 (N) (N) (%)
Tumor location    
Upper Third 5 10 33.3
Middle Third 41 22 65
Lower Third 18 10 64.3
Morphology    
Depressed 3 14 17.6
Non-Depressed 58 31 65.1
Tumor size   
≤3 cm 32 31 50.8
>3 cm 30 13 69.8
Histology    
Differentiated 27 16 62.7
Undifferentiated 37 26 58.7
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compatible with other reports (Bohle et al., 2011; Mocellin 
et al., 2011; Kutup et al., 2012; Mandai and Yasuda, 2012; 
De Angelis et al., 2013). A definite explanation cannot 
be offered by the authors in this regard; but attributions 
could be made to the limited number of patients and also 
the stage of diagnosis of GC. In addition, in the present 
study the location and size of tumors are associated with 
accuracy of EUS staging, where in cases with tumors 
located in the middle and lower part of the stomach, the 
EUS accuracy was higher than other parts. The accuracy 
was the lowest in those with tumors in the upper parts. 
These findings are comparable with previous reports. 
These findings may be due to the difference in the 
thickness of stomach layers, presence of fibrosis or blood 
vessels surrounding the tumor that making EUS evaluation 
difficult. Along with these issues, we have to also consider 
the limited number of cases. 
In the present study, a weighted kappa, which assigns 
less weight to agreement as categories are further apart, 
was calculated. The EUS T staging and the pathological T 
staging demonstrated moderate consistency (Kappa=0.53, 
Moderate agreement=0.41-0.60) (Viera and Garrett, 
2005). Also the EUS N staging and the pathological N 
staging demonstrated substantial agreement (Kappa=0.66, 
substantial agreement=0.61-0.80) (Viera and Garrett, 
2005). Although in our study, the factors affecting EUS 
accuracy were the location and size of tumor, we were 
not able to demonstrate a significant association between 
them. This result is comparable with other studies as 
reported by Tsuzuki, kim and Park (Park et al., 2011; 
Tsuzuki et al., 2011; Kim et al., 2014). In comparison 
with previous reports, the macroscopic morphology of 
lesions were not associated with EUS accuracy; this could 
be related to the low number of depressed lesions (Lee 
et al., 2012; Mandai and Yasuda, 2012; De Angelis et al., 
2013). In addition, the issue regarding the pathological 
type of lesions still remains a challenging item and was not 
associated with the accuracy of EUS staging in our study. 
For the clarification of this matter a multicentre study with 
more cases is required. Furthermore, when considering the 
limitations of this study, firstly, the numbers of participants 
were not enough in all stages of GC, and secondly, the 
greater part of our participants had large gastric tumors, 
providing us with a limited number of patients with small 
tumors, making comparison between should be considered 
carefully.
As a conclusion, in gastric cancer, it is vital to carefully 
detect the disease stage before initiation of treatment and 
consequently select the modality of treatment such as 
being surgery or endoscopic resection. In this study, we 
endeavored to compare preoperative EUS staging results 
with post surgery histopathology findings. Based on our 
findings the accuracy of EUS concerning the tumors that 
was located in the middle part of the stomach and the size 
of the tumor was more than 3 cm is higher.
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